Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab

Bing Liao1, Carlos Kamiya-Matsuoka1, Xiang Fang1

  • 1Department of Neurology (B.L., X.F., R.G.S.), The University of Texas Medical Branch, Galveston; and Department of Neuro-Oncology (C.K.-M.), The University of Texas MD Anderson Cancer Center, Houston.

Abstract

No abstract available in PubMed .